Ropes & Gray LLP

• Bio News

  Radionetics Oncology Enters Into Strategic Agreement With Lilly on its proprietary GPCR targeting small molecule radiopharmaceuticals

  Warmest congratulations to Eli Lilly and Radionetics Oncology!

  2024年7月2日

  3800